Intensive chemotherapy with G-CSF mobilization yields improved peripheral blood progenitor cell (PBPC) collection, quicker recovery after high dose chemotherapy (HDC) and reduces progression risk compared to G-CSF alone for mobilization.

被引:0
|
作者
Gajewski, JL [1 ]
Donato, M [1 ]
Anderlini, P [1 ]
Korbling, M [1 ]
Saliba, R [1 ]
Khouri, I [1 ]
Rondon, G [1 ]
Giralt, S [1 ]
Ueno, N [1 ]
Andersson, B [1 ]
Molldrem, J [1 ]
Ippoliti, C [1 ]
Buzdar, A [1 ]
Valero, V [1 ]
Bast, R [1 ]
Theriault, R [1 ]
Hortabagyi, G [1 ]
Champlin, R [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2953
引用
收藏
页码:665A / 665A
页数:1
相关论文
共 50 条
  • [31] Use of G-CSF plus CFA vs G-CSF alone for mobilization of peripheral blood progenitor cells in children with malignant diseases.
    Vazquez, JE
    Jimenez, E
    Ibarra, E
    Ayometzi, MT
    Bello, SA
    Martinez, A
    BLOOD, 2001, 98 (11) : 334B - 334B
  • [32] Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone
    Hartung, G
    Uharek, L
    Zeis, M
    Glass, B
    Steinmann, J
    Dreger, P
    Krönke, M
    Schmitz, N
    BONE MARROW TRANSPLANTATION, 1998, 21 : S16 - S20
  • [33] PBPC mobilization in multiple myeloma: High-dose chemotherapy plus G-CSF vs two different dosages of G-CSF during steady-state.
    Goldschmidt, H
    Hegenbart, U
    Cremer, F
    Kiel, K
    Wallmeier, M
    Hohaus, S
    Haas, R
    Moos, M
    BLOOD, 1996, 88 (10) : 1610 - 1610
  • [34] Plerixafor plus G-CSF (P plus G) compared with G-CSF alone (G) for hematopoietic progenitor cell (HPC) mobilization in AL amyloidosis (AL).
    Dhakal, Binod
    Strouse, Christopher Sun
    Arce-Lara, Carlos
    D'souza, Anita
    Esselman, Jean
    Eastwood, Daniel
    Pasquini, Marcelo C.
    Saber, Wael
    Drobyski, William R.
    Hari, Parameswaran
    Hamadani, Mehdi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Amifostine in conjunction with granulocyte colony-stimulating factor (G-CSF) enhances chemotherapy-elicited peripheral blood progenitor cell mobilization.
    Carlo-Stella, C
    Dodero, A
    Garau, D
    Regazzi, E
    Mangoni, L
    Franciosi, V
    Vasini, G
    Passalacqua, R
    Cocconi, G
    Rizzoli, V
    BONE MARROW TRANSPLANTATION, 1998, 21 : S196 - S196
  • [36] THE ENGRAFTMENT CAPACITY OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED WITH CHEMOTHERAPY +/- G-CSF
    PETTENGELL, R
    DEMUYNCK, H
    TESTA, NG
    DEXTER, TM
    INTERNATIONAL JOURNAL OF CELL CLONING, 1992, 10 : 59 - 61
  • [37] Endogenous chemokine production after G-CSF induced peripheral blood stem cell (PBSC) mobilization.
    Engelhardt, M
    Guo, Y
    Nauck, M
    Wäsch, R
    Schwabe, M
    Bertz, H
    Finke, J
    BLOOD, 1999, 94 (10) : 147B - 147B
  • [38] Hematopoietic progenitor cell collection and neoplastic cell contamination in breast cancer patients receiving chemotherapy plus granulocyte-colony stimulating factor (G-CSF) or G-CSF alone for mobilization
    Bertolini, F
    Lanza, A
    Peccatori, F
    Zibera, C
    Gibelli, N
    Perotti, C
    Da Prada, GA
    Torretta, L
    Corocchio, E
    Martinelli, G
    della Cuna, GR
    ANNALS OF ONCOLOGY, 1998, 9 (08) : 913 - 916
  • [39] Peripheral blood stem cell mobilization using sequential G-CSF alone followed by CTX/VP-16/G-CSF
    Akard, LP
    Dugan, MJ
    Greenspan, A
    Hanks, S
    Thompson, JM
    Wiemann, MC
    Jansen, J
    BLOOD, 1996, 88 (10) : 3655 - 3655
  • [40] Successful Peripheral Blood Stem Cell Mobilization with G-CSF Alone in Poor Mobilizers
    Araki, Raita
    Nishimura, Ryosei
    Mase, Shintaro
    Noguchi, Kazuhiro
    Fujiki, Toshihiro
    Kuroda, Rie
    Maeba, Hideaki
    Yachie, Akihiro
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S61 - S61